# Vectibix

NDC: 55513-956
Generic name: panitumumab
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20061010

FDA application: BLA125147

## Active ingredients

- PANITUMUMAB: 400 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-956"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-956
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0fa4bca-f245-4d92-ae29-b0c630a315c2